<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport, Inc. Retains KCSA Strategic Communications as U.S. Investor Relations Counsel

March 27, 2014

LAKE FOREST, California, March 27, 2014 – Cryoport, Inc. (OTC BB: CYRX), the only end-to-end cryogenic logistics solutions provider, today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations program.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, KCSA Strategic Communications, Investor Relations

Cryoport Increases Revenues By 149% For The First Nine Months of Fiscal 2014

February 13, 2014

LAKE FOREST, CA – February 13, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and nine months ended December 31, 2013.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Revenue

Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point-of-Service Orthopedic Care

February 5, 2014

Philadelphia/Lake Forest - February 5, 2014 - Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX)  today  announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa’s cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport’s proprietary, purpose-built cold chain logistics solutions for cell-based and advanced biologic tissue forms with Liventa Bioscience’s distribution capability to “point-of-use” US-based orthopedic care providers.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Liventa

Cryoport Revenues Increased 151% for the First Half of Fiscal 2014

November 18, 2013

LAKE FOREST, CA – November 18, 2013 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and six months ended September 30, 2013.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Revenue

Cryoport to Present at LD Micro Growth Conference on December 3, 2013

November 15, 2013

LAKE FOREST, CA – November 15, 2013 — Cryoport, Inc. (OTCBB: CYRX) today announced that Chief Executive Officer Jerrell Shelton and Chief Financial Officer Robert Stefanovich are scheduled to present to investors at the 6th Annual LD Micro Growth Conference on Tuesday, December 3, 2013 at 3:00 PM PST. 

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, LD Micro Growth Conference, frozen shipping solution

Cryoport and Ocasa Align for Global Cold Chain

September 26, 2013

LAKE FOREST, CA – September 26, 2013 — Cryoport, Inc. (OTCBB: CYRX) and OCASA, Inc. have entered into a master services agreement to provide global cold chain logistics solutions for life science and biotech commodities requiring cryogenic temperatures. OCASA will have access to Cryoport’s full range of cryogenic business solution capabilities including its proprietary Cryoport Express® Shippers and cloud-based logistics management software platform, the CryoportalTM. Cryoport will leverage OCASA’s global logistics network to provide more complete global services to its customers. In conjunction with Cryoport and OCASA providing each other with logistics solutions, the Companies will engage in co-marketing, joint sales activities, and a wide range of customer-driven support requirements to provide comprehensive and seamless solutions to the life sciences and biotech industries.

Read More


Tags: Dry Shipper, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Zoetis, Pfizer, frozen shipping solution, Vaccines, Animal HealthDry Shipper, OCASA